A detailed history of North Star Investment Management Corp. transactions in Novartis Ag stock. As of the latest transaction made, North Star Investment Management Corp. holds 1,391 shares of NVS stock, worth $148,948. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,391
Previous 1,358 2.43%
Holding current value
$148,948
Previous $144,000 10.42%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$106.13 - $120.89 $3,502 - $3,989
33 Added 2.43%
1,391 $159,000
Q2 2024

Aug 05, 2024

SELL
$92.57 - $107.37 $2,129 - $2,469
-23 Reduced 1.67%
1,358 $144,000
Q1 2023

Apr 27, 2023

BUY
$80.03 - $92.81 $80 - $92
1 Added 0.07%
1,381 $127,000
Q4 2022

Jan 11, 2023

SELL
$75.55 - $92.52 $45,178 - $55,326
-598 Reduced 30.23%
1,380 $0
Q1 2022

May 03, 2022

BUY
$80.11 - $90.62 $1,281 - $1,449
16 Added 0.82%
1,978 $174,000
Q2 2021

Jul 13, 2021

BUY
$85.24 - $94.15 $4,602 - $5,084
54 Added 2.83%
1,962 $179,000
Q1 2021

Apr 19, 2021

BUY
$83.5 - $98.47 $1,169 - $1,378
14 Added 0.74%
1,908 $163,000
Q2 2020

Jul 16, 2020

SELL
$80.93 - $91.1 $43,702 - $49,194
-540 Reduced 22.19%
1,894 $165,000
Q1 2020

Apr 23, 2020

BUY
$70.67 - $99.01 $61,058 - $85,544
864 Added 55.03%
2,434 $201,000
Q3 2019

Oct 03, 2019

BUY
$85.54 - $94.26 $134,297 - $147,988
1,570 New
1,570 $136,000
Q2 2019

Jul 15, 2019

SELL
$75.4 - $92.8 $118,378 - $145,696
-1,570 Closed
0 $0
Q1 2019

Apr 10, 2019

BUY
$75.32 - $86.15 $828 - $947
11 Added 0.71%
1,570 $151,000
Q2 2018

Jul 20, 2018

BUY
$64.91 - $73.36 $1,103 - $1,247
17 Added 1.1%
1,559 $118,000
Q3 2017

Oct 06, 2017

BUY
$74.14 - $77.27 $114,323 - $119,150
1,542
1,542 $132,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $230B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track North Star Investment Management Corp. Portfolio

Follow North Star Investment Management Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Star Investment Management Corp., based on Form 13F filings with the SEC.

News

Stay updated on North Star Investment Management Corp. with notifications on news.